These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2378925)

  • 21. The frontal lobes and schizophrenia.
    Weinberger DR; Aloia MS; Goldberg TE; Berman KF
    J Neuropsychiatry Clin Neurosci; 1994; 6(4):419-27. PubMed ID: 7841813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A neuropsychological study of early onset schizophrenia.
    Hoff AL; Harris D; Faustman WO; Beal M; DeVilliers D; Mone RD; Moses JA; Csernansky JG
    Schizophr Res; 1996 May; 20(1-2):21-8. PubMed ID: 8794490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of controls.
    Gale I
    Br J Psychiatry; 1991 Jun; 158():862-3. PubMed ID: 1750913
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia.
    Dieci M; Vita A; Silenzi C; Caputo A; Comazzi M; Ferrari L; Ghiringhelli L; Mezzetti M; Tenconi F; Invernizzi G
    Schizophr Res; 1997 May; 25(1):33-42. PubMed ID: 9176925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcortical dysfunction in schizophrenia: a comparison with Parkinson's disease and Huntington's disease.
    Hanes KR; Andrewes DG; Pantelis C; Chiu E
    Schizophr Res; 1996 May; 19(2-3):121-8. PubMed ID: 8789910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive subtypes of chronic schizophrenia.
    Heinrichs RW; Awad AG
    Schizophr Res; 1993 Mar; 9(1):49-58. PubMed ID: 8096391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the concept of frontal-subcortical dementia relevant to schizophrenia?
    Pantelis C; Barnes TR; Nelson HE
    Br J Psychiatry; 1992 Apr; 160():442-60. PubMed ID: 1349250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic signs in patients with paranoid and nonparanoid schizophrenia.
    Kinney DK; Yurgelun-Todd DA; Woods BT
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):447-9. PubMed ID: 1422173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smooth pursuit eye movements and neuropsychological impairments in schizophrenia.
    Gråwe RW; Levander S
    Acta Psychiatr Scand; 1995 Aug; 92(2):108-14. PubMed ID: 7572255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the neuropsychological case-study approach be applied to schizophrenia?
    Shallice T; Burgess PW; Frith CD
    Psychol Med; 1991 Aug; 21(3):661-73. PubMed ID: 1946855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological signs and sustained attention impairment in schizophrenia.
    Chen EY; Lam LC; Chen RY; Nguyen DG; Kwok CL; Au JW
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(1):1-5. PubMed ID: 11315511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flat affect in schizophrenia: a test of neuropsychological models.
    Blanchard JJ; Kring AM; Neale JM
    Schizophr Bull; 1994; 20(2):311-25. PubMed ID: 8085134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia.
    Buchanan RW; Strauss ME; Kirkpatrick B; Holstein C; Breier A; Carpenter WT
    Arch Gen Psychiatry; 1994 Oct; 51(10):804-11. PubMed ID: 7944870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment resistant chronic psychopathology and CT scans in schizophrenia.
    Ota T; Maeshiro H; Ishido H; Shimizu Y; Uchida R; Toyoshima R; Ohshima H; Takazawa A; Motomura H; Noguchi T
    Acta Psychiatr Scand; 1987 Apr; 75(4):415-27. PubMed ID: 3591423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation Scale.
    Sewell RA; Perry EB; Karper LP; Bell MD; Lysaker P; Goulet JL; Brenner L; Erdos J; d'Souza DC; Seibyl JP; Krystal JH
    Schizophr Res; 2010 Dec; 124(1-3):1-12. PubMed ID: 20855185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms.
    Pantelis C; Stuart GW; Nelson HE; Robbins TW; Barnes TR
    Am J Psychiatry; 2001 Aug; 158(8):1276-85. PubMed ID: 11481163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The psychobiology of first-episode schizophrenia.
    Waring EM
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S33-7. PubMed ID: 8564915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.